188 related articles for article (PubMed ID: 10617598)
21. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development.
Tijchon E; van Emst L; Yuniati L; van Ingen Schenau D; Havinga J; Rouault JP; Hoogerbrugge PM; van Leeuwen FN; Scheijen B
Haematologica; 2016 Jul; 101(7):e272-6. PubMed ID: 27036158
[No Abstract] [Full Text] [Related]
23. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
24. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
Doidge R; Mittal S; Aslam A; Winkler GS
PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473
[TBL] [Abstract][Full Text] [Related]
25. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
26. BTG2, its family and its tutor.
Duriez C; Moyret-Lalle C; Falette N; El-Ghissassi F; Puisieux A
Bull Cancer; 2004; 91(7-8):E242-53. PubMed ID: 15381462
[TBL] [Abstract][Full Text] [Related]
27. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling.
Park S; Lee YJ; Lee HJ; Seki T; Hong KH; Park J; Beppu H; Lim IK; Yoon JW; Li E; Kim SJ; Oh SP
Mol Cell Biol; 2004 Dec; 24(23):10256-62. PubMed ID: 15542835
[TBL] [Abstract][Full Text] [Related]
28. [Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis].
Puisieux A; Magaud JP
Bull Cancer; 1999 Apr; 86(4):358-64. PubMed ID: 10341341
[TBL] [Abstract][Full Text] [Related]
29. BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms.
Morel AP; Sentis S; Bianchin C; Le Romancer M; Jonard L; Rostan MC; Rimokh R; Corbo L
J Cell Sci; 2003 Jul; 116(Pt 14):2929-36. PubMed ID: 12771185
[TBL] [Abstract][Full Text] [Related]
30. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK
J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic human papillomaviruses block expression of the B-cell translocation gene-2 tumor suppressor gene.
Cullmann C; Hoppe-Seyler K; Dymalla S; Lohrey C; Scheffner M; Dürst M; Hoppe-Seyler F
Int J Cancer; 2009 Nov; 125(9):2014-20. PubMed ID: 19551855
[TBL] [Abstract][Full Text] [Related]
32. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.
Duriez C; Falette N; Audoynaud C; Moyret-Lalle C; Bensaad K; Courtois S; Wang Q; Soussi T; Puisieux A
Gene; 2002 Jan; 282(1-2):207-14. PubMed ID: 11814693
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
34. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
[TBL] [Abstract][Full Text] [Related]
35. mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence.
Hwang SS; Lim J; Yu Z; Kong P; Sefik E; Xu H; Harman CCD; Kim LK; Lee GR; Li HB; Flavell RA
Science; 2020 Mar; 367(6483):1255-1260. PubMed ID: 32165587
[TBL] [Abstract][Full Text] [Related]
36. Altered cerebellum development and impaired motor coordination in mice lacking the Btg1 gene: Involvement of cyclin D1.
Ceccarelli M; Micheli L; D'Andrea G; De Bardi M; Scheijen B; Ciotti M; Leonardi L; Luvisetto S; Tirone F
Dev Biol; 2015 Dec; 408(1):109-25. PubMed ID: 26524254
[TBL] [Abstract][Full Text] [Related]
37. Human carbon catabolite repressor protein (CCR4)-associative factor 1: cloning, expression and characterization of its interaction with the B-cell translocation protein BTG1.
Bogdan JA; Adams-Burton C; Pedicord DL; Sukovich DA; Benfield PA; Corjay MH; Stoltenborg JK; Dicker IB
Biochem J; 1998 Dec; 336 ( Pt 2)(Pt 2):471-81. PubMed ID: 9820826
[TBL] [Abstract][Full Text] [Related]
38. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
[TBL] [Abstract][Full Text] [Related]
39. The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex.
Dolezal E; Infantino S; Drepper F; Börsig T; Singh A; Wossning T; Fiala GJ; Minguet S; Warscheid B; Tarlinton DM; Jumaa H; Medgyesi D; Reth M
Nat Immunol; 2017 Aug; 18(8):911-920. PubMed ID: 28628091
[TBL] [Abstract][Full Text] [Related]
40. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
